Historical study of acute hepatitis B in subjects with or without hepatitis C infection

Eur J Intern Med. 2012 Sep;23(6):e146-9. doi: 10.1016/j.ejim.2012.03.007. Epub 2012 Mar 28.

Abstract

Background: The epidemiological pattern of hepatitis B virus infection in Italy has greatly changed over the past decades. The aim of the study was to evaluate during time the epidemiological features of acute hepatitis B cases referred to an Infectious Disease Unit in North-East of Italy between 1978 and 1995.

Patients and methods: Stored sera of 183 cases were tested for HBV markers, HBV genotypes, anti-Delta and anti-HCV.

Results: Anti-HBcIgM was positive in all cases. Mean age increased from 30.2 years in 1978 to 37.5 in 1995 (P<0.01). Significant increase was observed in proportion of cases reporting intravenous drug use from 11.5% to 29.6% (P<0.03). Chronicity rate was as low as 1.1%. Mean days of hospitalization significantly decreased. HBV genotype determination showed that majority of cases was infected by genotype D, but its prevalence decreased from 88.2% in 1978 to 75.0% in 1995. Delta coinfection was present in 8.2%. The prevalence of HCV in patients with acute HBV was 35.0%; it fluctuated from 26.2% to 44.2%, mostly related (53.1%) to intravenous drug use. Dual infection did not lead to a more severe course of disease.

Conclusions: From this retrospective study, remarkable fluctuations in the prevalence of dual HBV-HCV infection before the implementation of HBV vaccination were observed. Presence of anti-HCV did not affect the course of acute HBV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Coinfection / epidemiology*
  • DNA, Viral / genetics
  • Female
  • Genotype
  • Hepatitis B / epidemiology*
  • Hepatitis B / prevention & control
  • Hepatitis B Vaccines / therapeutic use
  • Hepatitis B virus / genetics
  • Hepatitis C / epidemiology*
  • Humans
  • Italy / epidemiology
  • Length of Stay / statistics & numerical data
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • Substance Abuse, Intravenous / epidemiology

Substances

  • DNA, Viral
  • Hepatitis B Vaccines